Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies

Journal Article · · mBio (Online)
 [1];  [1];  [1];  [1];  [1];  [2];  [3];  [4];  [4];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1] more »;  [2];  [5];  [6];  [6];  [3];  [3];  [3];  [3];  [3];  [7];  [3];  [3];  [3];  [8];  [8];  [5];  [9];  [10];  [2];  [3];  [3];  [3];  [1];  [1] « less
  1. University of Pennsylvania, Philadelphia, PA (United States)
  2. Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
  3. Duke University School of Medicine, Durham, NC (United States)
  4. University of Pennsylvania, Philadelphia, PA (United States); The Wistar Institute, Philadelphia, PA (United States)
  5. The Scripps Research Institute, La Jolla, CA (United States)
  6. Centre de Recherche du CHUM, Montreal, QC (Canada); Univ. of Montreal, QC (Canada)
  7. Bioqual, Inc., Rockville, MD (United States)
  8. National Institutes of Health (NIH), Bethesda, MD (United States)
  9. San Diego Biomedical Research Institute, CA (United States)
  10. The Scripps Research Institute, La Jolla, CA (United States); Ragon Institute of MGH, Harvard and MIT, Cambridge, MA (United States)
HIV-1 and its SIV precursors share a broadly neutralizing antibody (bNAb) epitope in variable loop 2 (V2) at the envelope glycoprotein (Env) trimer apex. Here, we tested the immunogenicity of germ line-targeting versions of a chimpanzee SIV (SIVcpz) Env in human V2-apex bNAb heavy-chain precursor-expressing knock-in mice and as chimeric simian-chimpanzee immunodeficiency viruses (SCIVs) in rhesus macaques (RMs). Trimer immunization of knock-in mice induced V2-directed NAbs, indicating activation of V2-apex bNAb precursor-expressing mouse B cells. SCIV infection of RMs elicited high-titer viremia, potent autologous tier 2 neutralizing antibodies, and rapid sequence escape in the canonical V2-apex epitope. Six of seven animals also developed low-titer heterologous plasma breadth that mapped to the V2-apex. Antibody cloning from two of these animals identified multiple expanded lineages with long heavy chain third complementarity determining regions that cross-neutralized as many as 7 of 19 primary HIV-1 strains, but with low potency. Negative stain electron microscopy (NSEM) of members of the two most cross-reactive lineages confirmed V2 targeting but identified an angle of approach distinct from prototypical V2-apex bNAbs, with antibody binding either requiring or inducing an occluded-open trimer. Probing with conformation-sensitive, nonneutralizing antibodies revealed that SCIV-expressed, but not wild-type SIVcpz Envs, as well as a subset of primary HIV-1 Envs, preferentially adopted a more open trimeric state. These results reveal the existence of a cryptic V2 epitope that is exposed in occluded-open SIVcpz and HIV-1 Env trimers and elicits cross-neutralizing responses of limited breadth and potency.
Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
Canada Research Chair on Retroviral Entry; Canadian Institutes of Health Research (CIHR); National Institutes of Health (NIH); USDOE
Grant/Contract Number:
89233218CNA000001
OSTI ID:
2470552
Journal Information:
mBio (Online), Journal Name: mBio (Online) Journal Issue: 1 Vol. 14; ISSN 2150-7511
Publisher:
American Society for Microbiology (ASM)Copyright Statement
Country of Publication:
United States
Language:
English

References (97)

Manipulating the Selection Forces during Affinity Maturation to Generate Cross-Reactive HIV Antibodies journal February 2015
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody journal April 2016
Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization journal July 2019
Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model journal October 2017
Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models journal December 2017
Co-evolution of HIV Envelope and Apex-Targeting Neutralizing Antibody Lineage Provides Benchmarks for Vaccine Design journal June 2018
Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth journal October 2018
The Chimpanzee SIV Envelope Trimer: Structure and Deployment as an HIV Vaccine Template journal May 2019
Neonatal Rhesus Macaques Have Distinct Immune Cell Transcriptional Profiles following HIV Envelope Immunization journal February 2020
Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition journal April 2020
Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeys journal January 2022
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design journal January 2019
A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge journal September 2019
Strategies for a multi-stage neutralizing antibody-based HIV vaccine journal August 2018
Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2 journal January 2013
Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved journal December 2014
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design journal November 2015
A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure journal April 2017
Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop journal May 2017
Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development journal September 2017
HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage journal November 2017
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure journal May 2018
Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers journal January 2019
Rhesus and cynomolgus macaque immunoglobulin heavy-chain genotyping yields comprehensive databases of germline VDJ alleles journal February 2021
Structural dynamics reveal isolate-specific differences at neutralization epitopes on HIV Env journal June 2022
High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies journal June 2009
A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site journal August 2015
HIV vaccinology: 2021 update journal January 2021
Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon journal November 2007
Antibody neutralization and escape by HIV-1 journal March 2003
Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz journal July 2009
Broad neutralization coverage of HIV by multiple highly potent antibodies journal September 2011
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus journal April 2013
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies journal March 2014
Open and closed structures reveal allostery and pliability in the HIV-1 envelope spike journal July 2017
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study journal May 2012
Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies journal October 2015
Conserved structural elements in the V3 crown of HIV-1 gp120 journal July 2010
Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env journal June 2015
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design journal December 2015
Common helical V1V2 conformations of HIV-1 Envelope expose the α4β7 binding site on intact virions journal October 2018
Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations journal July 2019
Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimer journal February 2022
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles journal February 2021
Advancing an HIV vaccine; advancing vaccinology journal December 2018
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies journal August 2022
Recent progress in broadly neutralizing antibodies to HIV journal October 2018
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers journal May 2020
Systematic analysis of the in situ crosstalk of tyrosine modifications reveals no additional natural selection on multiply modified residues journal December 2014
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection journal May 2008
Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding journal December 2012
Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex journal November 2014
Envelope residue 375 substitutions in simian–human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques journal May 2016
Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop journal October 2016
Conditional antibody expression to avoid central B cell deletion in humanized HIV-1 vaccine mouse models journal March 2020
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection journal June 2009
IgBLAST: an immunoglobulin variable domain sequence analysis tool journal May 2013
Coevolution of HIV-1 and broadly neutralizing antibodies journal July 2019
Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection journal January 2014
IMGT/V-QUEST: IMGT Standardized Analysis of the Immunoglobulin (IG) and T Cell Receptor (TR) Nucleotide Sequences journal June 2011
Ontogeny-based immunogens for the induction of V2-directed HIV broadly neutralizing antibodies journal January 2017
Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies journal January 2017
The HIV-1 envelope glycoprotein structure: nailing down a moving target journal January 2017
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target journal September 2009
Antibodies in HIV-1 Vaccine Development and Therapy journal September 2013
Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions journal October 2014
Visualizing antibody affinity maturation in germinal centers journal February 2016
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses journal October 2019
Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth journal November 2020
Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies journal March 2017
Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env journal November 2021
Correlates of Protection Induced by Vaccination journal May 2010
New SHIVs and Improved Design Strategy for Modeling HIV-1 Transmission, Immunopathogenesis, Prevention, and Cure journal May 2021
Simian-Human Immunodeficiency Virus SHIV.CH505-Infected Infant and Adult Rhesus Macaques Exhibit Similar Env-Specific Antibody Kinetics, despite Distinct T-Follicular Helper and Germinal Center B Cell Landscapes journal May 2019
The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection journal March 2011
Simian-Human Immunodeficiency Virus SHIV.CH505 Infection of Rhesus Macaques Results in Persistent Viral Replication and Induces Intestinal Immunopathology journal September 2019
Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques journal April 2021
Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses journal April 2017
Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies journal December 2013
Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors journal July 2011
Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. journal January 1993
Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D journal November 1994
Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1. journal January 1994
Simian Immunodeficiency Virus Infection in Wild-Caught Chimpanzees from Cameroon journal January 2005
Antibody Recognition of CD4-Induced Open HIV-1 Env Trimers journal December 2022
Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1 journal September 2002
Enhancing the Proteolytic Maturation of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins journal March 2002
Neutralization Properties of Simian Immunodeficiency Viruses Infecting Chimpanzees and Gorillas journal April 2015
Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee journal June 2017
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers journal September 2018
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies journal September 2013
SONAR: A High-Throughput Pipeline for Inferring Antibody Ontogenies from Longitudinal Sequencing of B Cell Transcripts journal September 2016
Structure and Diversity of the Rhesus Macaque Immunoglobulin Loci through Multiple De Novo Genome Assemblies journal October 2017
Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants journal October 2015
Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies journal May 2017
HIV-1 Env trimer opens through an asymmetric intermediate in which individual protomers adopt distinct conformations journal March 2018
New tools for automated high-resolution cryo-EM structure determination in RELION-3 journal November 2018